- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06877104
Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression (HEALED)
March 25, 2026 updated by: Kirstin Leitner, University of Pennsylvania
The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Healing at Home (H@H) 2.0 is a comprehensive technology-based postpartum support program which provides 24/7 support to individuals through use of an SMS chatbot for six weeks postpartum.
This will be a randomized controlled trial (RCT) with an intervention arm consisting of patients who are planning to be discharged at routine timing (as determined by their clinical team) with access to H@H 2.0 postpartum SMS chatbot platform and a control arm which consists of usual postpartum care.
Study Type
Interventional
Enrollment (Estimated)
156
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Meaghan G McCabe, MPH
- Phone Number: 973-747-2824
- Email: meaghan.mccabe@pennmedicine.upenn.edu
Study Contact Backup
- Name: Angelina Malenda
- Phone Number: 551-482-3655
- Email: angelina.malenda@pennmedicine.upenn.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Hospital of the University of Pennsylvania
-
Contact:
- Angelina Malenda
- Phone Number: (551) 482-3655
- Email: angelina.malenda@pennmedicine.upenn.edu
-
Principal Investigator:
- Kirstin Leitner, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
- Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
- Able to speak, read and write English
- Age ≥18
- Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
- Completion of clinically administered EPDS during inpatient stay
- Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery
Exclusion Criteria:
- Unable to provide informed consent
- Baby not discharged with mother at postpartum discharge
- Does not have access to a mobile phone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of care
Routine postpartum care.
|
|
|
Experimental: Healing @ Home Program (H@H 2.0)
Routine postpartum care and the use of an algorithm-based text message support program for six weeks.
|
Healing @ Home 2.0 is a clinically used comprehensive technology-based postpartum support program, which provides 24/7 support to individuals through use of a text message based chatbot for six weeks postpartum.
Content of H@H 2.0 includes anticipatory guidance regarding physical recovery, infant care and feeding, clinical algorithms to respond to urgent patient needs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Edinburgh Postnatal Depression Scale (EPDS) Screening Score
Time Frame: At 6 weeks postpartum
|
Scores from the validated EPDS screening tool will be calculated using standard scoring criteria for each of the 10 items.
A score of 9 or greater or indication of suicide ideation will be used to indicate a positive depression screen.
|
At 6 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum visit attendance
Time Frame: Up to 3 months postpartum
|
Whether or not the patient attended their routine postpartum visit which should occur around the 6-week postpartum mark.
We will accept routine postpartum visits up to 12-weeks postpartum.
|
Up to 3 months postpartum
|
|
Count of unscheduled emergency room/postpartum triage visits
Time Frame: Up to 6 weeks postpartum
|
The number of unscheduled visits, reason for visit, whether or not patient was admitted to hospital in the first 6 weeks postpartum will be counted
|
Up to 6 weeks postpartum
|
|
Mode of feeding
Time Frame: At baseline and 6 weeks postpartum
|
Patient asked mode of feeding at two time points.
Options are exclusively breastfeeding, formula feeding only, or both breast and formula feeding.
|
At baseline and 6 weeks postpartum
|
|
Scores of self-efficacy in infant care
Time Frame: At baseline and at 6 weeks postpartum
|
Scores from the validated Self-efficacy in the Nurturing Role (SENR) tool will be calculated using Likert scale scoring criteria for each of the 16 items.
Negative items are reverse-scored such that higher scores on the items always reflect greater self-efficacy.
|
At baseline and at 6 weeks postpartum
|
|
Knowledge of postpartum warning signs
Time Frame: At baseline and at 6 weeks postpartum
|
Using a question from the Pregnancy Risk Assessment measure survey (PRAMS) to ask patients to identify warning signs of complications that can occur after birth
|
At baseline and at 6 weeks postpartum
|
|
Score of Postpartum sleep: quality
Time Frame: At baseline and at 6 weeks postpartum
|
One question Likert scale ranking quality of sleep from terrible to excellent.
|
At baseline and at 6 weeks postpartum
|
|
Postpartum sleep: hours
Time Frame: At baseline and at 6 weeks postpartum
|
Average number of hours slept in the past 7 days.
|
At baseline and at 6 weeks postpartum
|
|
Postpartum pain score
Time Frame: 24 hours prior to discharge from hospital
|
Scores from a 10-item question from the validated Brief Pain Inventory short form will be calculated using Likert scale scoring criteria with scores ranging from 0-100.
Higher scores mean higher pain.
|
24 hours prior to discharge from hospital
|
|
Social support and maternal functioning score
Time Frame: At 6 weeks postpartum
|
Scores from the validated Barkin Index of Maternal Functioning tool will be calculated using Likert scale scoring criteria for each of the 20 questions.
The total score ranges from 0 to 120, with a score of 120 representing perfect functioning.
|
At 6 weeks postpartum
|
|
Implementation outcome: Acceptability of Intervention Measure
Time Frame: At 6 weeks postpartum
|
4-item Likert scale where scores can range from 4 to 20. High scores indicate higher acceptability.
Given to the intervention group only.
|
At 6 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kirstin Leitner, MD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
March 8, 2025
First Submitted That Met QC Criteria
March 13, 2025
First Posted (Actual)
March 14, 2025
Study Record Updates
Last Update Posted (Actual)
March 27, 2026
Last Update Submitted That Met QC Criteria
March 25, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 857508
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression, Postpartum
-
Women and Infants Hospital of Rhode IslandNot yet recruitingPostpartum Anxiety | Paternal Postpartum Depression
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
-
Jordan University of Science and TechnologyActive, not recruitingPostpartum Depression | Postpartum Depression (PPD)Jordan
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Women's Health Research Institute...CompletedPostpartum Depression | Perinatal Disorder | Postpartum Disorder | Perinatal Depression | Postpartum Anxiety | Postnatal DepressionCanada
-
University of CoimbraEnrolling by invitationPostPartum DepressionPortugal
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalCompletedPostpartum Depression | Postpartum Anxiety | Postpartum Blues | Postpartum Mood DisorderCanada
-
Afyonkarahisar Health Sciences UniversityNot yet recruitingPostpartum Depression | Postpartum Anxiety
-
University Hospital, ToulouseCompletedPostnatal Depression | Postpartum Depression (PPD)France
Clinical Trials on Healing @ Home Program (H@H 2.0)
-
Elizabeth K RhodusEmory University; National Institute on Aging (NIA)CompletedMental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurocognitive Disorders | Neurodegenerative Diseases | Dementia | Alzheimer Disease | TauopathiesUnited States
-
New York UniversityVisiting Nurse Service of New YorkWithdrawn
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompleted
-
Arab American University (Palestine)CompletedType 2 Diabetes MellitusPalestinian Territory, occupied
-
Akdeniz UniversityThe Scientific and Technological Research Council of TurkeyCompletedDeveloping the ABEP-H | Determining the Effect of ABEP-HTurkey
-
NYU Langone HealthTerminated
-
Northwestern UniversityAmerican Society of Transplant SurgeonsTerminatedKidney TransplantUnited States
-
Wills EyeCompleted
-
Stanford UniversityAnonymous DonorRecruitingAutism Spectrum Disorder | Autism | ASDUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingHER2-positive Breast Cancer | Adjuvant TherapyChina